Is TACE plus tyrosine kinase inhibitors and immune checkpoint inhibitors superior to TACE plus tyrosine kinase inhibitors for unresectable hepatocellular carcinoma: the debate continues
Hepatol Int. 2024 Feb 8.
doi: 10.1007/s12072-024-10651-z.
Online ahead of print.
1 Department of Vascular Surgery, Nantong First People's Hospital, The Second Affiliated Hospital of Nantong University, 666 Shengli Road, Chongchuan District, Nantong, 226014, Jiangsu Province, China.
2 Department of Vascular Surgery, Nantong First People's Hospital, The Second Affiliated Hospital of Nantong University, 666 Shengli Road, Chongchuan District, Nantong, 226014, Jiangsu Province, China. mzbdoctor@163.com.